Evidence map›Paper›PMID 34622035›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa countries: A retrospective study.

Nicholaus P Mnyambwa, Doreen Philbert, Godfather Kimaro, Steve Wandiga, Bruce Kirenga, Blandina Theophil Mmbaga, Winters Muttamba, Irene Najjingo, Simon Walusimbi, Roseline Nuwarinda and 13 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Reimagining tuberculosis detection in Somalia: from passive to active case finding.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The gut microbiome: A line of defense against tuberculosis development.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 3 countries.

Nicholaus P MnyambwaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Doreen PhilbertNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Godfather KimaroNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Steve WandigaKenya Medical Research Institute, Kisumu, Kenya.
Bruce KirengaMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Blandina Theophil MmbagaKilimanjaro Clinical Research Institute and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Winters MuttambaMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Irene NajjingoMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Simon WalusimbiMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Roseline NuwarindaInfectious Diseases Institute, Mulago Hospital, Kampala, Uganda.
Douglas OkellohKenya Medical Research Institute, Kisumu, Kenya.
Hadja SemvuaKilimanjaro Clinical Research Institute and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
James NgochoKilimanjaro Clinical Research Institute and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Mbazi SenkoroNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Okoboi StephenInfectious Diseases Institute, Mulago Hospital, Kampala, Uganda.
Barbara CastelnuovoInfectious Diseases Institute, Mulago Hospital, Kampala, Uganda.
Aman WilfredNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Erick MginaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Cassiana SangaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Fredrick AmanNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Amosi KahwaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Sayoki MfinangaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
Esther NgadayaNational Institute for Medical Research Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.
National Institute for Medical Research · TZMakerere University · UGKilimanjaro Christian Medical Centre · TZKenya Medical Research Institute · KEMulago Hospital · UGInfectious Diseases Institute · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEast Africa countries (Tanzania, Kenya, and Uganda) are among tuberculosis high burdened countries globally. As we race to accelerate progress towards a world free of tuberculosis by 2035, gaps related to screening and diagnosis in the cascade care need to be addressed.

methodsWe conducted a three-year (2015-2017) retrospective study using routine program data in 21 health facilities from East Africa. Data abstraction were done at tuberculosis clinics, outpatient departments (OPD), human immunodeficiency virus (HIV) and diabetic clinics, and then complemented with structured interviews with healthcare providers to identify possible gaps related to integration, screening, and diagnosis of tuberculosis. Data were analyzed using STATA™ Version 14.1.

resultsWe extracted information from 49,454 presumptive TB patients who were registered in the 21 facilities between January 2015 and December 2017. A total of 9,565 tuberculosis cases were notified; 46.5% (4,450) were bacteriologically confirmed and 31.5% (3,013) were HIV-infected. Prevalence of tuberculosis among presumptive pulmonary tuberculosis cases was 17.4%. The outcomes observed were as follows: 79.8% (7,646) cured or completed treatment, 6.6% (634) died, 13.3% (1,270) lost to follow-up or undocumented and 0.4% (34) treatment failure. In all countries, tuberculosis screening was largely integrated at OPD and HIV clinics. High patient load, weak laboratory specimen referral system, shortage of trained personnel, and frequent interruption of laboratory supplies were the major cited challenges in screening and diagnosis of tuberculosis.

conclusionScreening and diagnostic activities were frequently affected by scarcity of human and financial resources. Tuberculosis screening was mainly integrated at OPD and HIV clinics, with less emphasis on the other health facility clinics. Closing gaps related to TB case finding and diagnosis in developing countries requires sustainable investment for both human and financial resources and strengthen the integration of TB activities within the health system.

Indexed as

DiagnosisIntegration, East AfricaPresumptive TBScreeningTuberculosis (TB)

Identifiers

PMID34622035
PMCPMC8481961
OpenAlexW3202079253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.